Takeda to Add 40 Jobs, Expand Irish Plant for Cancer Drug

Dec 06, 2016

in-Pharma Technologist

Takeda reportedly will build a high containment production facility at its site in Dublin, Ireland to support the manufacturing of its oncology product Ninlaro (ixazomib), according to an article in in-Pharma Technologist.

The Japanese manufacturer said it is investing about $43 million to expand its Grange Castle, Dublin, facility and add 40 new jobs. The site is its worldwide center for API manufacturing.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments